RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 245-252

  Bravo Nuevo, Arturo ^a   Sugimoto, Hikaru ^b   Iyer, Seema ^a   Fallon, Zachary ^a   Lucas, Jason M ^a   Kazerounian, Shiva ^a   Prendergast, George C ^c   Kalluri, Raghu ^b   Shapiro, Nathan I ^a   Benjamin, Laura E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Center for Life Sciences   (United States)

^c LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SIMVASTATIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRESS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEPLETION; STREPTOZOCIN DIABETES; WOUND HEALING;

EID: 79251526181     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.040     Document Type: Article

References (28)

1. Huang M, Prendergast GC: RhoB in cancer suppression. Histol Histopathol 2006, 21:213-218
2. Adini I, Rabinovitz I, Sun JF, Prendergast GC, Benjamin LE: RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 2003, 17:2721-2732
3. Wheeler AP, Ridley AJ: RhoB affects macrophage adhesion, integrin expression and migration. Exp Cell Res 2007, 313:3505-3516
4. Fritz G, Kaina B: Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006, 6:1-14
5. Mazieres J, Tovar D, He B, Nieto-Acosta J, Marty-Detraves C, Clanet C, Pradines A, Jablons D, Favre G: Epigenetic regulation of RhoB loss of expression in lung cancer. BMC Cancer 2007, 7:220
6. Wang S, Yan-Neale Y, Fischer D, Zeremski M, Cai R, Zhu J, Asselbergs F, Hampton G, Cohen D: Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line. Oncogene 2003, 22:6204-6213
7. Hackam DJ, Rotstein OD, Schreiber A, Zhang W, Grinstein S: Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J Exp Med 1997, 186:955-966 (Pubitemid 27407356)
8. Adamson P, Marshall C, Hall A, Tilbrook P: Post-translational modifications of p21rho proteins. J Biol Chem 1992, 267:20033-20038
9. Rydgren T, Vaarala O, Sandler S: Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice. J Pharmacol Exp Ther 2007, 323:180-185
10. Zhu B, Shen H, Zhou J, Lin F, Hu Y: Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection. Nephron Exp Nephrol 2005, 101:e1-e8
11. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP: An improved method for isolation of mouse pancreatic islets. Transplantation 1985, 40:437-438
12. Zeisberg M, Hanai J-i, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003, 9:964-968
13. Brocco E, Fioretto P, Mauer M, Saller A, Carraro A, Frigato F, Chiesura-Corona M, Bianchi L, Baggio B, Maioli M, Abaterusso C, Velussi M, Sambataro M, Virgili F, Ossi E, Nosadini R: Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int Suppl 1997, 63:40-44
14. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001, 50:537-546
15. Murata M, Takahashi A, Saito I, Kawanishi S: Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol 1999, 57:881-887
16. Dhawan S, Tschen SI, Bhushan A: Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 2009, 23:906-911
17. Tschen SI, Dhawan S, Gurlo T, Bhushan A: Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009, 58:1312-1320
18. Covington DS, Xue H, Pizzini R, Lally KP, Andrassy RJ: Streptozotocin and alloxan are comparable agents in the diabetic model of impaired wound healing. Diabetes Res 1993, 23:47-53
19. Laufs U, Liao JK: Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998, 273:24266-24271
20. Turner SJ, Zhuang S, Zhang T, Boss GR, Pilz RB: Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors. Biochem Pharmacol 2008, 75:405-413
21. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G: Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004, 10:2742-2750
22. Marlow LA, Reynolds LA, Cleland AS, Cooper SJ, Gumz ML, Kurakata S, Fujiwara K, Zhang Y, Sebo T, Grant C, McIver B, Wadsworth JT, Radisky DC, Smallridge RC, Copland JA: Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. Cancer Res 2009, 69:1536-1544
23. Couderc B, Pradines A, Rafii A, Golzio M, Deviers A, Allal C, Berg D, Penary M, Teissie J, Favre G: In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther 2008, 15:456-464
24. Cemek M, Kaga S, Simsek N, Buyukokuroglu ME, Konuk M: Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin- induced diabetic rats. J Nat Med 2008, 62:284-293
25. Coskun O, Kanter M, Korkmaz A, Oter S: Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005, 51:117-123
26. Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 1994, 43:1326-1333
27. Mori H, Shichita T, Yu Q, Yoshida R, Hashimoto M, Okamoto F, Torisu T, Nakaya M, Kobayashi T, Takaesu G, Yoshimura A: Suppression of SOCS3 expression in the pancreatic beta-cell leads to resistance to type 1 diabetes. Biochem Biophys Res Commun 2007, 359:952-958
28. Rydgren T, Sandler S: The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase. Biochem Biophys Res Commun 2009, 379:1076-1079